Neurorehabilitation Devices
Middle East · 1 shared keyword
Updated
Reviewed by Vidhi Upadhyay
Middle East Neurology Devices Market Industry Trends and Forecast to 2034: Segmented by (Product, Application, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034
Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.
Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.
$670.6 Mn total, 2026–2034
| Year | Market size | Change that year | Since 2025 |
|---|---|---|---|
| 2024 (estimate) | $448.9 Mn | — | — |
| 2025 (base) | $493.8 Mn | +$44.9 Mn | — |
| 2026 (forecast) | $543.2 Mn | +$49.4 Mn | +10% |
| 2027 (forecast) | $597.5 Mn | +$54.3 Mn | +21% |
| 2028 (forecast) | $657.2 Mn | +$59.7 Mn | +33.1% |
| 2029 (forecast) | $723.0 Mn | +$65.7 Mn | +46.4% |
| 2030 (forecast) | $795.3 Mn | +$72.3 Mn | +61.1% |
| 2031 (forecast) | $874.8 Mn | +$79.5 Mn | +77.2% |
| 2032 (forecast) | $962.3 Mn | +$87.5 Mn | +94.9% |
| 2033 (forecast) | $1.06 Bn | +$96.2 Mn | +114.4% |
| 2034 (forecast) | $1.16 Bn | +$105.9 Mn | +135.8% |
Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.
| Market size, 2025 | $493.8 Mn placeholder estimate |
|---|---|
| Forecast, 2034 | $1.16 Bn placeholder estimate |
| Growth (CAGR), 2025–2034 | 10.0% placeholder estimate |
| Years | 2024 historical · 2025 base year · 2026–2034 forecast |
| Segments | Product, application and end user (see all) |
| Key players | Medtronic, Boston Scientific Corporation, Abbott Laboratories, Stryker, Integra Life Sciences Corporation and 1 more (see all) |
| Formats | PDF, PPTX, XLSX |
Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.
Neurology devices diagnose and treat diseases of the brain, spine and nerves, such as stimulators, monitors and shunts.
Key segments of the neurology devices market include product (Neurostimulators, Neurovascular Devices and Cerebrospinal Fluid Management) and application (Epilepsy, Parkinson's Disease and Chronic Pain).
An ageing population, more chronic disease, a rise in elective procedures and steady advances in implants and instruments are driving the neurology devices market.
Smart implants, less invasive techniques and growing access to surgery in emerging economies give the neurology devices market room to grow.
Strict approval rules, price pressure from hospital buyers and shortages of trained surgeons in some regions hold back the neurology devices market.
The neurology devices market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.
In some of the countries we cover here, medical devices are regulated by SFDA (Saudi Arabia)[1], EDE (UAE)[2], Ministry of Public Health (Qatar)[3] and AMAR (Israel)[4]. How care is paid for in some of these countries: free public care and CHI-regulated insurance (Saudi Arabia)[5], mandatory health insurance (UAE)[6], public care and compulsory insurance (Qatar)[3] and four health funds (Israel)[4].
[1] Saudi Food and Drug Authority. Checked 14 Nov 2026.
[2] Emirates Drug Establishment. Checked 14 Nov 2026.
[3] Ministry of Public Health, Qatar. Checked 19 Nov 2026.
[4] Israel Ministry of Health. Checked 19 Nov 2026.
[5] Council of Health Insurance. Checked 14 Nov 2026.
[6] Ministry of Human Resources and Emiratisation. Checked 14 Nov 2026.
Medical device rules, such as the US FDA 510(k) and PMA pathways and the EU Medical Device Regulation, govern how neurology devices products are approved and monitored. Reimbursement codes and hospital purchasing policies decide how widely they are used in Middle East.
From our blog
Middle East · 1 shared keyword
Middle East · 1 shared keyword
Middle East
Middle East
Middle East
Middle East
Digital Health · Middle East
Pharmaceuticals · Middle East
Pharmaceuticals · Middle East
Healthcare Services · Middle East
Pharmaceuticals · Middle East
Pharmaceuticals · Middle East